Home › Trial NCT04725448
Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma
- Trial IDNCT04725448
- StatusUnknown
- PhasePhase 2
- Study typeInterventional
- SponsorSichuan Cancer Hospital and Research Institute
- Enrollment27
- Start date2021-04-06
- ConditionsPulmonary Sarcomatoid Carcinoma · Non-small Cell Lung Cancer · Lung Diseases · Thoracic Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.